15 July 2020 : Clinical Research
Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients
Shoufeng Liu12AE, Peipei Liu2BCDEF, Po Wang3BC, Fang Zhang4BD, Lijun Wang5BD, Yu Wang6BD, Hao Lu7B, Xiaofeng Ma4AG*DOI: 10.12659/MSM.924593
Med Sci Monit 2020; 26:e924593
Table 2 Complications and adverse events.
| Complication or event | Control n=30 | Argatroban n=30 | P value |
|---|---|---|---|
| Complications | |||
| Deaths | 0 (0) | 0 (0) | 1.00 |
| Myocardial infarctions | 0 (0) | 0 (0) | 1.00 |
| Recurrent strokes | 1 (3) | 0 (0) | 0.31 |
| Cerebral hemorrhage | 0 (0) | 0 (0) | 1.00 |
| Hemorrhage of digestive tract | 0 (0) | 1 (3) | 0.31 |
| Fever (>38°C) | 1 (3) | 1 (3) | 1.00 |
| Event | |||
| All events | |||
| At least one adverse event | 1 (3) | 1 (3) | 1.00 |
| Any adverse event leading to discontinuation | 0 (0) | 0 (0) | 1.00 |
| Any serious adverse event | 0 (0) | 0 (0) | 1.00 |
| Infection after stroke | 1 (3) | 1 (3) | 1.00 |
| Suspected lung infection | 1 (3) | 0 (0) | 0.31 |
| Urinary tract infection | 0 (0) | 0 (0) | 1.00 |
| Upper respiratory tract infection | 0 (0) | 1 (3) | 0.31 |
| Digestive system infection | 0 (0) | 0 (0) | 1.00 |
| Herpes virus infection | 0 (0) | 0 (0) | 1.00 |
| Antibiotic therapy | 1 (3) | 0 (0) | 0.31 |
| Data are n (%). | |||